Argenica Therapeutics LtdASX: AGN

Last Patient Dosed in Phase 2 Stroke Trial

Apr 11, 2025 at 2:42 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment